2020
DOI: 10.1038/s41592-019-0692-4
|View full text |Cite
|
Sign up to set email alerts
|

Computational methods for single-cell omics across modalities

Abstract: Single-cell omics approaches provide high resolution data on cellular phenotypes, developmental dynamics and communication networks in diverse tissues and conditions. Emerging technologies now measure different modalities of individual cells, such as genomes, epigenomes, transcriptomes and proteomes, in addition to spatial profiling. Combined with analytical approaches, these data open new avenues for accurate reconstruction of gene regulatory and signaling networks driving cellular identity and function. Here… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
149
0
3

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 179 publications
(152 citation statements)
references
References 32 publications
0
149
0
3
Order By: Relevance
“…Since the first step of scLink was partially motivated by our scImpute method [29] and additional imputation methods for single-cell gene expression data have also become available [83], an alternative approach to the construction of gene co-expression networks is to apply conventional inference methods on imputed gene expression data. However, we would like to discuss two potential issues with this approach.…”
Section: Discussionmentioning
confidence: 99%
“…Since the first step of scLink was partially motivated by our scImpute method [29] and additional imputation methods for single-cell gene expression data have also become available [83], an alternative approach to the construction of gene co-expression networks is to apply conventional inference methods on imputed gene expression data. However, we would like to discuss two potential issues with this approach.…”
Section: Discussionmentioning
confidence: 99%
“…With the increase in experimental protocols that generate large amounts of data (Efremova & Teichmann, ) (such as sequencing, microscopy) and the accumulation of large data repositories (e.g., of medical records), we expect DGMs to find numerous new applications and challenges. For example, the case of clinical trial data is particularly sensitive because of privacy issues: It may be possible to identify the participants from inspection of their data.…”
Section: Perspectivesmentioning
confidence: 99%
“…While these findings improve our present understanding of cellular determinants of ageing with regard to motility patterns, and its utility to serve as robust biomarkers of ageing, it remains unclear whether and how cells transition across motility states as a function of increasing age. This diversity in cellular phenotypes with age is likely linked to underlying molecular programs, cellular subtypes and cell cycle states that together influence the motility patterns of cells 5,33 . We anticipate that future work is needed to address this, which will require the use of cells derived from large cohorts of healthy donors (cross-sectional and longitudinal) imaged for long periods of time (order of days), coupled with single-cell molecular assessments.…”
Section: Singlementioning
confidence: 99%